The AI in Business Podcast

In this episode of the AI in Business Podcast, Brett Kiley, Executive Director of Customer Experience and Client Solutions at CVS Health, joins us for a compelling discussion on the evolving landscape of customer interactions. With over two decades of experience, Brett shares how CVS navigates the challenges of personalization, efficiency, and seamless service across their retail, pharmacy, and health services divisions. To access Emerj’s frameworks for AI readiness, ROI, and strategy, visit Emerj Plus at emerj.com/p1. 

Michael Berger, Head of Insure AI at Munich Re, dives into the crucial impact of global AI legislation on the insurance sector. He unpacks how the EU AI Act's risk-based framework contrasts with the US's litigation-driven approach. Michael highlights essential legal precedents regarding AI liability that inform risk management strategies. The discussion also emphasizes the distinction between large foundational models and fine-tuned variants, guiding industry leaders in navigating AI governance while balancing innovation with risk.

Steffen Hoffmann, Managing Director of Bosch UK, shares insights on revolutionizing industries with AI. He explains Bosch’s innovative black grass detection system in agriculture that cuts chemical use while optimizing costs. The conversation dives into how AI enhances quality control in manufacturing through intelligent inspection systems. Hoffmann also highlights the evolution of AI in smart homes and HR, underlining the importance of technology in improving operational efficiency rather than replacing human roles.

Join Paul Ronan, Chief Technology Officer at FE fundinfo, as he dives into the transformative role of AI in asset and wealth management. With over 30 years in the financial data industry, he discusses the contrasting perspectives on AI adoption—balancing excitement with caution regarding data quality and regulatory issues. Paul emphasizes the need for robust data foundations and strategies for effective AI integration. Discover how firms can enhance efficiency, personalize client experiences, and navigate the evolving landscape of investment management.

Dan Elton, a Staff Scientist at the National Human Genome Research Institute, dives into the fascinating interplay between AI and genomics. He discusses AlphaFold, which accurately predicts protein structures, revolutionizing drug development. Elton also explores how machine learning enhances polygenic risk prediction, allowing for improved disease risk assessment based on genetic markers. Additionally, he touches on AI's role in gene editing and the data challenges faced in managing sensitive genetic information, paving the way for future advances in personalized healthcare.

Ben Webster, VP of AI Solutions at NLP Logix, dives into the intricate world of de-identifying patient data for healthcare AI applications. He discusses the increasing reliance of hospitals on first-party data to ensure compliance while harnessing AI's analytical strength. The conversation highlights the cost and scalability challenges of proper de-identification and the legal complexities involved. Ben also emphasizes the importance of organizational readiness for change and the need for healthcare leaders to foster a culture that embraces AI integration.

Nishtha Jain, Head of Innovation and Digital Technology at Takeda Pharmaceuticals, discusses AI's game-changing role in the biopharma industry. She highlights breakthroughs like Google DeepMind's AlphaFold that speed up drug development. Jain delves into the complexities of data accessibility and the regulatory challenges posed by AI integration. The conversation also covers the ethical implications of AI models, emphasizing the need for fairness and accountability in medical advancements, ensuring equitable outcomes in drug development.

Nick Lewis, Managing Director for the High Risk Client Unit at Standard Chartered Bank, shares insights on the evolving role of banks in fraud detection and anti-money laundering compliance. He discusses how regulatory shifts are pushing banks to take on more responsibilities with limited resources. The conversation highlights the evolution of sanctions and the critical role AI plays in enhancing detection methods. Lewis also emphasizes the urgent need for collaboration between banks and law enforcement to tackle serious crimes like human trafficking.

Today’s guest is Mike Matta, Co-founder and CEO of Solink. Solink is a cloud video security and analytics platform that works with your existing cameras, access controls, and operational technologies like POS and labor management, helping you modernize and improve security and operations without costly upgrades. Mike joins today’s show to discuss how AI-driven video data is helping retailers mitigate risk, improve loss prevention strategies, and drive operational efficiencies. Today’s episode is part of a special series on driving video security in retail through data sponsored by Solink. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

Today’s guest is Ylan Kazi, Chief Data and AI Officer at Blue Cross Blue Shield of North Dakota. Ylan returns to the show to discuss the latest developments in AI adoption within healthcare. The conversation explores key obstacles, including cultural resistance, the need for an AI Hippocratic Oath, and the risks of holding AI to unrealistic standards. Ylan also examines how agentic AI—capable of operating across systems to accomplish complex tasks—is reshaping healthcare operations. From optimizing administrative processes to rethinking claims management, AI has the potential to drive efficiency while maintaining human oversight where it matters most. This episode is sponsored by Searce. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.